IDiyas

For the Inventor, By the Inventor

Ramsgate, United Kingdom

Ian T Barnish

USPTO Granted Patents = 21

Average Co-Inventor Count = 3.2

ph-index = 6

Forward Citations = 261(Granted Patents)


Location History:

  • Ramsgate, EN (1976 - 1978)
  • Kent, GB (1992 - 1993)
  • Ramsgate, GB (1979 - 1994)

Company Filing History:

goldMedal21 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 1976-1994

Loading Chart...
21 patents (USPTO):Explore Patents
1. 5362902 - N-(1-(2-carboxyethyl35cloalkylcarbonyl)-beta-alanine derivatives for (1994-11-08),
2. 5260467 - Glutaric acid derivatives and preparation thereof (1993-11-09),
3. 5192800 - Glutaramide diuretic agents (1993-03-09),
4. 5157138 - Glutaric acid derivatives and preparation thereof (1992-10-20),
5. 5030654 - Glutaramide diuretic agents (1991-07-09),
6. 4341792 - Heterobicyclic keto- and amino-acids, esters and amides (1982-07-27),
7. 4299820 - Therapeutic process employing amides of L and DL phenylglycines (1981-11-10),
8. 4243672 - 5-Substituted 2-pyrroleglyoxylic acids, 5-substituted 2-pyrrolylglycines (1981-01-06),
9. 4239779 - Use of phenylglyoxylic acids and derivatives thereof in the treatment of (1980-12-16),
10. 4219566 - Phenylglyoxylic acids and derivatives thereof (1980-08-26),
11. 4218474 - Derivatives of L- and DL-4-hydroxyphenylglycine (1980-08-19),
12. 4186210 - Method of treatment with glycinamides (1980-01-29),
13. 4185117 - Method of treatment with glycinamides (1980-01-22),
14. 4185116 - L- and DL- Phenylglycines to treat diseases or conditions attributable (1980-01-22),
15. 4179521 - L- and DL-Phenylglycines to treat diseases or conditions attributable to (1979-12-18),

Title: **Ian T Barnish: Innovator in Pharmaceutical Chemistry**

Introduction

Ian T Barnish is a prominent inventor based in Ramsgate, GB, with an impressive portfolio of 21 patents. His work primarily focuses on advancements in pharmaceutical chemistry, specifically in the development of compounds that can lead to novel medical treatments.

Latest Patents

Among his most recent innovations are patents related to N-(1-(2-carboxyethyl3-cloalkylcarbonyl)-beta-alanine derivatives and glutaric acid derivatives. These inventions provide substantially optically pure 2(S)-stereoisomeric forms of specific compounds, along with processes for their preparation. The compounds serve as intermediates for the development of antihypertensive agents, showcasing Barnish's commitment to advancing healthcare through innovative chemistry.

Career Highlights

Ian T Barnish is currently affiliated with Pfizer Corporation, a leading global biopharmaceutical company. His work at Pfizer involves extensive research and development in the field of drug formulation, where his inventions contribute significantly to the company's pipeline of therapeutic agents. His 21 patents reflect his dedication to innovation and excellence in pharmaceutical chemistry.

Collaborations

Throughout his career, Ian has collaborated with esteemed colleagues, including John C Danilewicz and Peter E Cross. These partnerships have led to the successful development of several key innovations, emphasizing the collaborative spirit of research and development within the pharmaceutical industry.

Conclusion

Ian T Barnish stands out as a key figure in the field of pharmaceutical innovations. With a strong record of patenting critical advancements, he continues to make significant contributions that could transform the landscape of medical treatments and improve patient outcomes worldwide. His work exemplifies the importance of innovation in fostering progress within the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…